Hong Dai1, Chunmei Wang2, Zhihai Yu1, Donglin He1, Kun Yu1, Yin Liu1, Sheng Wang1. 1. 1 Department of Urology Surgery, Three Gorges Central Hospital , Chongqing, China . 2. 2 Department of Traumatology, Three Gorges Central Hospital , Chongqing, China .
Abstract
OBJECTIVE: STAT3 is an important protein in Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway that facilitates B-cell lymphoma 2 (Bcl-2) expression. MiR-17 was found to be significantly reduced in prostate cancer tissues and cells, suggesting that it might be a tumor suppressor in prostate cancer tumorigenesis. Bioinformatics analysis showed the complementary binding site between miR-17 and STAT3. This study aimed to investigate the role of miR-17 in regulating JAK-STAT signaling pathway, as well as prostate cancer cell proliferation and apoptosis. MATERIALS AND METHODS: Dual luciferase assay was used to verify the targeted relationship between miR-155 and STAT3. LNCaP cells were cultured in vitro and divided into four groups, including mimic NC, miR-17 mimic, si-NC, and si-STAT3 groups. STAT3, p-STAT3, and Bcl-2 expressions were tested by western blot. Cell apoptosis was detected by flow cytometry. Cell proliferation was assessed by EdU staining. RESULTS: MiR-17 mimic transfection significantly reduced the relative luciferase activity in HEK293T cells. MiR-17 targeted regulated STAT3 expression. MiR-17 expression and cell apoptosis were obviously declined, while STAT3 level and cell proliferation markedly were elevated in LNCaP cells compared with RWPE-1 cells. MiR-17 mimic and/or si-STAT3 transfection significantly downregulated the expression of STAT3, p-STAT3, and Bcl-2, attenuated cell proliferation, and enhanced cell apoptosis in LNCaP cells. CONCLUSIONS: Upregulation of miR-17 inhibited LNCaP cell proliferation and induced cell apoptosis by downregulating the expression of STAT3, p-STAT3, and Bcl-2.
OBJECTIVE:STAT3 is an important protein in Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway that facilitates B-cell lymphoma 2 (Bcl-2) expression. MiR-17 was found to be significantly reduced in prostate cancer tissues and cells, suggesting that it might be a tumor suppressor in prostate cancer tumorigenesis. Bioinformatics analysis showed the complementary binding site between miR-17 and STAT3. This study aimed to investigate the role of miR-17 in regulating JAK-STAT signaling pathway, as well as prostate cancer cell proliferation and apoptosis. MATERIALS AND METHODS: Dual luciferase assay was used to verify the targeted relationship between miR-155 and STAT3. LNCaP cells were cultured in vitro and divided into four groups, including mimic NC, miR-17 mimic, si-NC, and si-STAT3 groups. STAT3, p-STAT3, and Bcl-2 expressions were tested by western blot. Cell apoptosis was detected by flow cytometry. Cell proliferation was assessed by EdU staining. RESULTS:MiR-17 mimic transfection significantly reduced the relative luciferase activity in HEK293T cells. MiR-17 targeted regulated STAT3 expression. MiR-17 expression and cell apoptosis were obviously declined, while STAT3 level and cell proliferation markedly were elevated in LNCaP cells compared with RWPE-1 cells. MiR-17 mimic and/or si-STAT3 transfection significantly downregulated the expression of STAT3, p-STAT3, and Bcl-2, attenuated cell proliferation, and enhanced cell apoptosis in LNCaP cells. CONCLUSIONS: Upregulation of miR-17 inhibited LNCaP cell proliferation and induced cell apoptosis by downregulating the expression of STAT3, p-STAT3, and Bcl-2.
Entities:
Keywords:
STAT3; apoptosis; miR-17; proliferation; prostate cancer
Authors: Chris W D Armstrong; Jonathan A Coulter; Chee Wee Ong; Pamela J Maxwell; Steven Walker; Karl T Butterworth; Oksana Lyubomska; Silvia Berlingeri; Rebecca Gallagher; Joe M O'Sullivan; Suneil Jain; Ian G Mills; Kevin M Prise; Robert G Bristow; Melissa J LaBonte; David J J Waugh Journal: NAR Cancer Date: 2020-07-03
Authors: Maria Jenvin Stoen; S Andersen; M Rakaee; M I Pedersen; L M Ingebriktsen; R M Bremnes; T Donnem; A P G Lombardi; T K Kilvaer; L T Busund; E Richardsen Journal: Sci Rep Date: 2021-07-05 Impact factor: 4.379
Authors: Jaroslaw Thomas Dankert; Marc Wiesehöfer; Elena Dilara Czyrnik; Bernhard B Singer; Nicola von Ostau; Gunther Wennemuth Journal: PLoS One Date: 2018-07-12 Impact factor: 3.240
Authors: Manuela Gries; Anne Christmann; Steven Schulte; Maximilian Weyland; Stephanie Rommel; Monika Martin; Marko Baller; Ralph Röth; Stefanie Schmitteckert; Marcus Unger; Yang Liu; Frederik Sommer; Timo Mühlhaus; Michael Schroda; Jean-Pierre Timmermans; Isabel Pintelon; Gudrun A Rappold; Markus Britschgi; Hilal Lashuel; Michael D Menger; Matthias W Laschke; Beate Niesler; Karl-Herbert Schäfer Journal: Mol Neurodegener Date: 2021-06-02 Impact factor: 14.195